Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Addex Therapeutics (GB:0QNV)
LSE:0QNV
Addex Therapeutics (0QNV) Share Price & Analysis
0 Followers
0QNV Stock Chart & Stats
Day’s RangeCHF0 - CHF0
52-Week RangeCHF0.06 - CHF0.24
Previous CloseCHF0.19
Volume0.00
Average Volume (3M)156.60K
Market Cap
CHF27.47M
Enterprise ValueCHF21.46M
Total Cash (Recent Filing)$6.96M
Total Debt (Recent Filing)$373.13K
Price to Earnings (P/E)-1.3
Beta0.64
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding385,670,100
10 Day Avg. Volume2,479
30 Day Avg. Volume156,605
Standard Deviation0.23
R-Squared0.03
Alpha0.00088
Financial Highlights & Ratios
Price to Book (P/B)-0.19
Price to Sales (P/S)212.55
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue25.86
Enterprise Value/Gross Profit15.09
Enterprise Value/Ebitda-1.28
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Addex Therapeutics News
PremiumCompany Announcements
Addex Therapeutics’ Epilepsy Drug Fails Key Trial
PremiumCompany Announcements
Addex Therapeutics Achieves Stronger Fiscal Position
PremiumCompany Announcements
Addex Launches Neurosterix with $63M for Neurological R&D
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
0.00% Mutual Funds
0.03% Other Institutional Investors
99.97% Public Companies and
Individual Investors
0QNV FAQ
What was Addex Therapeutics’s price range in the past 12 months?
Addex Therapeutics lowest share price was CHF0.06 and its highest was CHF0.24 in the past 12 months.
What is Addex Therapeutics’s market cap?
Currently, no data Available
When is Addex Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Addex Therapeutics’s earnings last quarter?
Currently, no data Available
Is Addex Therapeutics overvalued?
According to Wall Street analysts Addex Therapeutics’s price is currently Overvalued.
Does Addex Therapeutics pay dividends?
Addex Therapeutics does not currently pay dividends.
What is Addex Therapeutics’s EPS estimate?
Addex Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Addex Therapeutics have?
Addex Therapeutics has 184,354,490 shares outstanding.
What happened to Addex Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Addex Therapeutics?
Currently, no hedge funds are holding shares in GB:0QNV
---
Addex Therapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
Addex Therapeutics
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.
---
Technical Analysis
---